Clinical trial
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With…
NCT00421889 · Valerio Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00421889 |
|---|---|
| Title | A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment |
| Official title | A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients With Advanced Solid Tumours |
| Lead sponsor | Valerio Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Bladder Cancer |
| Intervention type | Drug |
| Interventions | belinostat, Paclitaxel, Carboplatin |
| Enrollment | 80 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jan 15, 2007 |
| Last update posted | Jul 28, 2015 |
| Countries | Denmark, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: